Use of intravenous cyclophosphamide in the prevention of corneal melt: Justified or not? [3]

Rheumatology

Volumn 44, Issue 2, 2005, Pages 257-258

  Clewes, Adrian R ^a   Tunn, E J ^a   Kaye, S ^a   Bucknall, R C ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; PENICILLAMINE; PREDNISOLONE;

ADULT; AGED; CASE REPORT; CATARACT; CATARACT EXTRACTION; CORNEA TRANSPLANTATION; DRUG PULSE THERAPY; DRUG USE; FEMALE; GRAFT FAILURE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KERATITIS; LETTER; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRIMARY PREVENTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC THERAPY; VISUAL IMPAIRMENT;

AGED; ARTHRITIS, RHEUMATOID; CORNEAL ULCER; CYCLOPHOSPHAMIDE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFUSIONS, INTRAVENOUS; MIDDLE AGED; TREATMENT OUTCOME;

EID: 14044273092     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keh442     Document Type: Letter

References (10)

1. Foster CS, Forstot SL, Wilson LA. Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis: effects of systemic immunosuppression. Ophthalmology 1984;91:1253-63.
2. Messmer EM, Foster S. Destructive corneal and scleral disease associated with rheumatoid arthritis: medical and surgical management. Cornea 1995;14:408-17.
3. Squirrell DM, Winfield J, Amos RS. Peripheral ulcerative keratitis, 'corneal melt' and rheumatoid arthritis: a case series. Br J Rheumatol 1999;38:1245-8.
4. Jifi-Bahool H, Saadeh C, O'Connor J. Peripheral ulcerative keratitis in the setting of rheumatoid arthritis: treatment with immunosuppressive therapy. Semin Arthritis Rheum 1995;25:67-73.
5. Riley GP, Harral RL, Watson PG et al. Collagenase (MMP-1) and TIMP-1 in destructive corneal disease associated with rheumatoid arthritis. Eye 1995;9:703-18.
6. Tauber J, Sainz de la Maza M, Hoang-Xuan T, Foster CS. An analysis of therapeutic decision making regarding immunosuppression chemotherapy for peripheral ulcerative keratitis. Cornea 1990;9:66-73.
7. Bernauer W, Ficker LA, Watson P, Dart JKG. The management of corneal perforations associated with rheumatoid arthritis: an analysis of 32 eyes. Ophthalmology 1995;102:1325-37.
8. Easty DL, Madden P, Jayson MIV. Systemic immunosuppression in marginal keratolysis. Trans Ophthalmol Soc UK 1978;98:410-7.
9. Foster CS. Immunosuppressive therapy for external ocular inflammatory disease. Ophthalmology 1980;87:140-9.
10. Jampol LM, West C, Goldberg MF. Therapy of scleritis with cytotoxic agents. Am J Ophthalmol 1978;86:266-71.